With a series of "warm government" incentives, the innovation vitality of Hubei's biomedical industry has been significantly enhanced
.
Data show that in 2022, Hubei Province will add 53 new drugs such as national Class 1 new drugs, children's rare disease drugs, and first generic drugs, and 25 Class III medical devices will be approved for registration
.
It is understood that in order to promote the development of the biomedical industry, Hubei Province has launched a series of "warm policies"
.
For example, the Hubei Provincial Drug Administration Bureau intervened early, guided the whole process, and served the R&D and innovation of drugs and devices in advance, and served the construction of key industrial parks in a "group" manner, serving 740 enterprises and solving 1,549 problems
.
Hubei has also successively issued 42 measures
to optimize the review and approval and promote the high-quality development of the biomedical industry.
In addition, an incentive policy for the transfer of drugs from outside the province was introduced, and 364 drug registration numbers were transferred throughout the year
.
Guide domestic high-quality medical device enterprises and products to transfer to Hubei agglomeration, quickly handle the transfer of 109 products of enterprises from other provinces to Hubei, quickly realize industrialization, and shorten the average certification period by more than half a year
.
Inspired by a series of "warm policies", in 2022, Hubei Province will add 53 new drugs such as national Class 1 new drugs, rare disease drugs for children, and first generic drugs
.
For example, in September 2022, the total flavonoid capsules developed by Renfu Pharmaceutical obtained marketing approval from the National Medical Products Administration and became a new traditional Chinese medicine
for the prevention and treatment of urinary stones.
According to the data, the total flavonoid part of Guangqian grass was isolated from the single flavor Chinese medicinal materials of Guangqian grass by using macroporous adsorption resin purification technology, and the effective part was combined to develop an innovative preparation of modern traditional Chinese medicine
.
Its characteristics are: clear effective substances, good stability, high quality controllability, and good safety; It is beneficial for anti-inflammatory, litholytic stone removal, painless stone removal, and prevention of stone formation
.
In children's rare disease drugs, such as clobazam tablets from Yichang Renfu, a subsidiary of Renfu Pharmaceutical, were approved for marketing as the first generic in China in September 2022
.
According to the data, it is a rare disease drug for children, which is used to treat refractory seizures in children, and is suitable for the combination treatment
of seizures in patients with Lennox-Gastaut syndrome (LGS) aged 2 years and above.
It is understood that in recent years, the development of the pharmaceutical industry in Hubei Province has achieved remarkable results, the total scale has grown steadily, and various professional fields have repeatedly achieved good results
.
The provincial drug regulatory department innovated the support model and played a combination of "policy, technology and service" to help the high-quality development of
Hubei's pharmaceutical industry.
In terms of innovation, Hubei upgraded the 4.
0 version of the smart approval system and explored the implementation of smart network offices, reducing the average time of registration, review and approval by nearly 70%.
Data show that in the past three years, 6 first-class innovative drugs in Hubei Province have been approved by the state, and the number of innovative drugs approved and the ability of drug innovation research and development have entered the national front
.
In 2021, the total sales of pharmaceutical commodities in Hubei Province reached 111.
4 billion yuan, and the technological innovation potential of pharmaceutical enterprises is accelerating
.
The industry said that the development of the pharmaceutical industry in Hubei Province is inseparable from professional talents and cutting-edge technology
.
For example, in June 2022, the Hubei Provincial Food and Drug Administration organized the "100 Professional Talents Intelligence Enterprise" activity, relying on the talent and technical advantages of Hubei Institute of Drug Supervision and Inspection to help enterprises solve problems and enhance their development stamina
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
